Expression and regulation of non-classical HLA-G in renal cell carcinoma

Tissue Antigens

Volumn 72, Issue 2, 2008, Pages 137-148

  Dunker, K ^a   Schlaf, G ^a   Bukur, J ^a   Altermann, W W ^a   Handke, D ^a   Seliger, B ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cancer; Human leukocyte antigen G; Immune evasion; Immune surveillance; Methylation; Renal cell carcinoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GAMMA INTERFERON; HLA G ANTIGEN; INTERLEUKIN 10; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DEMETHYLATION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; TRANSCRIPTION REGULATION; UPREGULATION;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC HETEROGENEITY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; K562 CELLS; KIDNEY NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER;

EID: 47549109221     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01090.x     Document Type: Article

References (54)

1. Kirszenbaum M, Djoulah S, Hors J, Prost S, Dausset J, Carosella ED. Polymorphism of HLA-G gene and protein. J Reprod Immunol 1999 : 43 : 105 9.
2. LeDiscorde M, LeDanff C, Moreau P, Rouass-Freiss N, Carosella ED. HLA-G *0105N null allele encodes functional HLA-G isoforms. Biol Reprod 2005 : 73 : 280 8.
3. Arnaiz-Villena A, Martinez-Laso J, Serrano-Vela JI, Reguera R, Moscoso R. HLA-G polymorphism and evolution. Tissue Antigens 2007 : 69 : 156 9.
4. Ellis SA, Sargent JL, Redman CW et al. Evidence for a novel HLA-antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 1986 : 59 : 595 601.
5. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992 : 89 : 3947 51.
6. Kirszenbaum M, Moreau P, Glückmann E, Dausset J, Carosella ED. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A 1994 : 91 : 4209 13.
7. Fuji T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994 : 153 : 5516 24.
8. Paul P, Cabestre FA, Ibrahim EC et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6 and -G7 transcripts in human transfected cells. Hum Immunol 2000 : 61 : 1138 49.
9. Park GM, Lee S, Park B et al. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated lysis. Biochem Biophys Res Commun 2004 : 313 : 606 11.
10. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED. The alpha 1 domain of HLA-G1 and HLA-G2 inhibits cytotoxocity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A 1997 : 94 : 5249 54.
11. Carosella ED, Moreau P, LeMaoult P et al. HLA-G and HLA-E: fundamental and pathophysiological aspects. Immunol Today 2000 : 21 : 532 4.
12. Cantoni C, Verdiani S, Falco M et al. P49, a putative HLA-class I specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol 1998 : 28 : 1980 90, Erratum in: Eur J Immunol 1998: 28: 3398.
13. Navarro F, Llano M, Bellon T et al. The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules on target cells. Eur J Immunol 1999 : 29 : 277 83.
14. Shirioishi M, Tsumoto K, Amano K et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 2003 : 100 : 8856 61.
15. Clements CS, Kjer-Nielsen L, Kostenko L et al. Crystal structure of HLA-G: a non classical MHC class I molecule at the fetal maternal interface. Proc Natl Acad Sci U S A 2005 : 102 : 3360 5.
16. Braud VM, Allan DS, O'Callaghan CA et al. HLA-E binds to natural killer cell CD94/Nkg2A, B and C. Nature 1998 : 391 : 795 9.
17. Rouass-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cell cytolysis. Proc Natl Acad Sci U S A 1997 : 94 : 11520 5.
18. Ponte M, Cantoni C, Biassoni R et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1 -specific receptor. Proc Natl Acad Sci U S A 1999 : 96 : 5674 9.
19. Navarro F, Llano M, Bellon T, Colonna M, Geraghty DE, Lopez-Botet M. The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999 : 29 : 277 83.
20. Riteau B, Menier C, Khalil-Daher C et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999 : 43 : 203 11.
21. O'Brian M, McCarthy T, Jenkins D et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001 : 58 : 1943 9.
22. Beydoun H, Saftlas AF. Association of human leucocyte antigen sharing with recurrent spontaneous abortions. Tissue Antigens 2005 : 65 : 123 35.
23. Shang-Mian Y, Balakier H, Motamedi G, Librach CL. Secretion of human leukocyte antigen-G by human embryos is associated with a higher in-vitro fertilization pregnancy rate. Fertil Steril 2005 : 83 : 30 6.
24. Rebmann V, Switala M, Eue I, Schwahn E, Merzenich M, Grosse-Wilde H. Rapid evaluation of soluble HLA-G in supernatants of in-vitro fertilized embryos. Hum Immunol 2007 : 68 : 251 8.
25. Lila N, Amrein C, Guillemain S et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002 : 105 : 1949 54.
26. Rouas-Freiss N, LeMaoult J, Moreau P et al. HLA-G in transplantation: a relevant molecule for inhibition of graft rejection? Am J Transplant 2003 : 3 : 11 6.
27. Rebmann V, Regel J, Stolke D, Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 2003 : 13 : 371 7.
28. Amiot L, Le Friec G, Sebti Y et al. HLA-G and lymphoproliferative disorders. Semin Cancer Biol 2003 : 13 : 379 85.
29. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. HLA-G proteins in cancer: do they provide tumour cells with an escape mechanism? Cancer Res 2005 : 65 : 10139 44.
30. El Ibrahim C, Allory Y, Commo F, Gattegno B, Callard P, Paul P. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the non-classical human leukocyte antigen-g molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma. Am J Pathol 2003 : 162 : 501 8.
31. Bukur J, Rebmann V, Grosse-Wilde H et al. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Cancer Res 2003 : 63 : 4107 11.
32. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000 : 25 : 315 9.
33. Pryde JG, Phillips JH. Fractionation of membrane proteins by temperature-induced phase separation in Triton X-114. Biochem J 1986 : 233 : 525 33.
34. Menier C, Saez B, Horejsi V et al. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of non-classical HLA class I molecules. Hum Immunol 2003 : 64 : 315 26.
35. Moreau P, Adrian-Cabestre F, Menier C et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999 : 11 : 803 11.
36. Urosevic M, Dummer R. HLA-G and IL-10 expression in human cancer - different stories with the same message. Semin Cancer Biol 2003 : 13 : 337 42.
37. Yang Y, Chu W, Geraghty DE, Hunt JS. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J Immunol 1996 : 156 : 4224 31.
38. Chu W, Yang Y, Geraghty DE, Hunt JS. Interferons enhance HLA-G mRNA and protein in transfected mouse fibroblasts. J Reprod Immunol 1999 : 42 : 1 15.
39. Levebvre S, Moreau P, Guiard V et al. Molecular mechanisms controlling constitutive and IFN-gamma-inducible HLA-G expression in various cell types. J Reprod Immunol 1999 : 43 : 213 24.
40. Wischnewski F, Pantel K, Schwarzenbeck H. Promotor demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Mol Cancer Res 2006 : 4 : 339 49.
41. Agraval A, Murphy RF, Agraval DF. DNA methylation in breast and colorectal cancers. Mod Pathol 2007 : 20 : 711 21.
42. Moreau P, Mouillot G, Rousseau P, Marcou C, Dausset J, Carosella ED. HLA-G gene repression is reversed by demethylation. Proc Natl Acad Sci U S A 2003 : 100 : 1191 6.
43. Real LM, Cabrera T, Collado A et al. Expression of HLA-G in human tumors is not a frequent event. Int J Cancer 1999 : 81 : 512 8.
44. Langat DK, Sue Platt J, Tawfik O, Fazleabas AT, Hunt JS. Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma. J Reprod Immunol 2006 : 71 : 75 86.
45. Urosevic M, Kurrer MO, Kamarashev J et al. Human leukocyte antigen G up-regulation in lung cancer associates with high grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 2001 : 159 : 817 24.
46. Bukur J, Seliger B. The role of HLA-G for protection of human renal cell carcinoma cells from immune-mediated lysis: implications for immunotherapies. Semin Cancer Biol 2003 : 13 : 353 9.
47. Blanco O, Tirado I, Muñoz-Fernández R, Abadía-Molina AC, García-Pacheco JM, Peña J, Olivares EG. Human decidual stromal cells express HLA-G: Effects of cytokines and decidualization. Human Reproduction 2008 : 23 : 144 52.
48. Yan WH, Lin AF, Chang CC, Ferrone S. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine. Cell Res 2005 : 15 : 523 31.
49. Momparler RL, Bovenzi V. DNA methylation and cancer. J Cell Physiol 2000 : 183 : 145 54.
50. Sigalotti L, Altomonte M, Colizzi F et al. 5-Aza-2'-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach? Blood 2003 : 101 : 4644 6 (as comment on: Blood 2002: 100: 2957-64).
51. Bovenzi V, Le NL, Cote S, Sinett D, Momparler LF, Momparler RL. DNA methylation of retinoic acid receptor in breast cancer and possible therapeutic role of 5'-aza-2'CdR. Anticancer Drugs 1999 : 10 : 471 6.
52. Guo ZS, Hong JA, Irvine KR et al. De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Cancer Res 2006 : 66 : 1105 13.
53. Coral S, Sigalotti L, Covre A, Hugues NJM, Natali PG, Maio M. 5-Aza-2'-deoxycytidine in cancer immunotherapy: a mouse to man story. Cancer Res 2007 : 67 : 2900.
54. Lettini AA, Guidoboni M, Fonsatti E, Anzalone L, Cortini E, Maio M. Epigenetic remodelling of DNA in cancer. Histol Histopathol 2007 : 22 : 1413 24.